AHA 2018 | Endocarditis Prophylaxis More Limited after AHA 2007 Guidelines

The incidence of infective endocarditis had decreased after AHA 2007 recommendations. At present, some patients are not receiving antibiotic prophylaxis as they should.

Disminuye la profilaxis de endocarditis luego de las guías del 2007After AHA restricted the use of antibiotic prophylaxis in 2007, high-risk patients undergoing dental procedures were prescribed less antibiotics. These patients had always been prescribed antibiotic prophylaxis, regardless they had less restrictive guidelines.  

 

At the same time, we observe a surprising trend towards lower incidence of infections endocarditis, which calls our attention. All these cases were presented at AHA annual meeting in 2018, and simultaneously published in JACC.


Read also: AHA 2018 | Freedom Long-Term Follow-up: Still in Favor of CABG.


In moderate risk patients, there was a more appropriate reduction of antibiotic prophylaxis after the new recommendations, with a more modest reduction in endocarditis rate for this group.

 

Even though this is an observational study, and we are no table to establish a cause-effect relationship between prescription frequency and endocarditis incidence, these finding support guideline recommendations.

 

However, we should not drop our guard: all high-risk patients undergoing dental procedures should receive antibiotic prophylaxis (not those at moderate risk).

 

Researchers estimate antibiotic prophylaxis has fallen across all groups since 2007 AHA recommendations. The drop has affected 52% of low or unknown risk patients, 64% of patients at moderate risk and 20% of high-risk patients.

 

Original title: Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations.

Reference: Thornhill et al. J Am Coll Cardiol. 2018;72:2543-2554.

 

profilaxis-antibiótica


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...